November 8, 2018 - By Mary Bollinger

MGC PHARMACEUTICALS LTD ORDINARY SHARES (OTCMKTS:MGCLF) had an increase of its shorted shares by 466.9%. It was issued in November by FINRA the 320,300 shorted shares on MGCLF. Previously was reported up change of 466.9% from 56,500 shares. Previous MGCLF’s position will need 1 days to recover. It has 435,600 average volume.

Ticker’s shares touched $0.03605 during the last trading session after 0.14% change.MGC Pharmaceuticals Limited has volume of 400 shares. Since November 8, 2017 MGCLF has 0.00% and is . MGCLF underperformed the S&P500 by 15.62%.

MGC Pharmaceuticals Limited operates as a medical and cosmetic cannabis firm in Australia and Slovenia.The firm is worth $52.67 million. It is developing phytocannabinoid as active pharmaceutical ingredients containing medicinal cannabis products.Currently it has negative earnings. The firm is also developing product formulation groups, including MGCND00EP1 for neurological disorders; MGCON00CA1 for oncology treatment and side effects; and MGCAU00SD1 for autoimmune treatments in inflammatory cases, as well as deep skin relief products under the DermaPlus brand.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.